Luye Pharma Group Ltd. (LYPHF)
PNK: LYPHF
· Real-Time Price · USD
0.27
0.00 (0.75%)
At close: Apr 29, 2025, 9:30 AM
0.75% (1D)
| Bid | 0.24 |
| Market Cap | 1.01B |
| Revenue (ttm) | 6.31B |
| Net Income (ttm) | 770.46M |
| EPS (ttm) | 0.02 |
| PE Ratio (ttm) | 13.4 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.27 |
| Volume | 100 |
| Avg. Volume (20D) | 62 |
| Open | 0.26 |
| Previous Close | 0.27 |
| Day's Range | 0.26 - 0.27 |
| 52-Week Range | 0.26 - 0.39 |
| Beta | 1.23 |
About LYPHF
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hyper...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Feb 18, 2021
Employees 5,234
Stock Exchange PNK
Ticker Symbol LYPHF
Website https://www.luye.cn